217 Queen Street West
Toronto, ON M5V 0R2
|Mr. James Andre-Charles Lanthier||Chief Exec. Officer||184.63k||N/A||1975|
|Mr. Arvin Ramos CPA||Chief Financial Officer||65.47k||N/A||1979|
|Mr. Joseph Araujo||Chief Scientific Officer, Member of Scientific Advisory Board & Director||19.26k||N/A||1977|
|Mr. Jason Atkinson||VP of Corp. Devel.||115.54k||N/A||N/A|
|Dr. Abdelmalik Slassi Ph.D.||Sr. VP of Innovation & Member of Scientific Advisory Board||N/A||N/A||N/A|
|Dr. Fiona Randall B.Sc., Ph.D.||Sr. VP of External Alliances & Scientific Strategy||N/A||N/A||N/A|
|Chris Irwin||Corp. Sec.||N/A||N/A||N/A|
Mindset Pharma Inc. operates as a neuro-pharmaceutical drug discovery and development platform company. It offers psychedelic compounds for treatment-resistant neurological and psychiatric disorders. The company was founded in 2019 and is based in Toronto, Canada.
Mindset Pharma Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.